Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?

Saved in:
Bibliographic Details
Title: Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?
Authors: Cheo SW; Department of Radiotherapy and Oncology, Hospital Wanita dan Kanak-kanak Sabah, Sabah, Malaysia. Electronic address: cheosengwee@gmail.com., Li MSC; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China., Huang DD; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Saw SPL; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Hendriks LEL; Department of Respiratory Medicine, Maastricht University Medical Centre, GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Université Paris Saclay, Department of Medicine, Gustave Roussy, Villejuif, France., Menis J; Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy., Addeo A; Oncology Service, University Hospital Geneva, Switzerland., Voon PJ; Department of Radiotherapy, Oncology and Palliative Care, Hospital Umum Sarawak, Sarawak, Malaysia.
Source: Cancer treatment reviews [Cancer Treat Rev] 2026 Feb; Vol. 143, pp. 103083. Date of Electronic Publication: 2025 Dec 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1967
DOI:10.1016/j.ctrv.2025.103083